Research Studies
Study Tracker
Chemical Pneumonitis Following Inhalation of Fluoride-Based Waterproofing Agent: A Case Series.Abstract
Abstract online at
https://onlinelibrary.wiley.com/doi/10.1002/ajim.70048
This study retrospectively analyzed seven cases of acute chemical pneumonitis caused by inhalation of fluoride-based waterproofing agents, that were admitted to Ningbo Second Hospital in September 2025. We summarize their clinical features, treatment strategies and outcomes. All patients had a clear history of occupational exposure to fluoride-containing gases. Early manifestations primarily consisted of respiratory irritation symptoms, with one critically-ill patient progressing to acute respiratory distress syndrome (ARDS) complicated by multiple organ failure within 24 h of exposure. Chest CT scans revealed characteristic acute lung injury changes. Case 7 exhibited elevated white blood cell counts, inflammatory markers, and significantly increased blood and urinary fluoride levels. All received comprehensive treatment, with respiratory support and corticosteroids as the core therapy. This case series indicates that this type of poisoning progresses rapidly. Early recognition, stepwise respiratory support based on oxygenation index, and early administration of high-dose corticosteroids are crucial for improving prognosis. These findings provide a reference for the clinical management of this rare but critical form of toxic lung injury.
Data Availability Statement
Case reports: data under control of the patients themselves.
- 1, , , , and , “Characterizing Emission and Breathing-Zone Concentrations Following Exposure Cases to Fluororesin-Based Waterproofing Spray Mists,” Journal of Occupational and Environmental Hygiene 1, no. 9 (2004): 582–592, https://doi.org/10.1080/15459620490490084.
- 2, and , “Fluoropolymer-Associated Illness,” Clinical Toxicology 52, no. 8 (2014): 848–855, https://doi.org/10.3109/15563650.2014.946610.
- 3. and , “Horse Rug Lung: Toxic Pneumonitis Due to Fluorocarbon Inhalation,” Occupational and Environmental Medicine 62, no. 6 (2005): 414–416, https://doi.org/10.1136/oem.2004.015784.
- 4. , , , , , and , “Acute Respiratory Syndrome After Inhalation of Waterproofing Sprays: A Posteriori Exposure-Response Assessment in 102 Cases,” Journal of Occupational and Environmental Hygiene 3, no. 5 (2006): 250–261, https://doi.org/10.1080/15459620600628845.
- 5. , , and , “Exposure to Fluoropolymers and VOCs During Spray Sealant Product Use,” Inhalation Toxicology 23, no. 11 (2011): 641–657, https://doi.org/10.3109/08958378.2011.603764.
- 6. , , , et al., “Toxicity of Fluoride: Critical Evaluation of Evidence for Human Developmental Neurotoxicity in Epidemiological Studies, Animal Experiments and In Vitro Analyses,” Archives of Toxicology 94, no. 5 (2020): 1375–1415, https://doi.org/10.1007/s00204-020-02725-2.
- 7. and , “Occupational Fluoride Exposure and Plasma Fluoride Levels in Man,” International Archives of Occupational and Environmental Health 58, no. 3 (1986): 179–190, https://doi.org/10.1007/BF00432099.
- 8. , , , et al., “Toxicity From Fluoropolymer-Containing Grout, Tile and Stone Floor Sealants Reported to the UK National Poisons Information Service 2009–2015,” Clinical Toxicology 55, no. 6 (2017): 585–588, https://doi.org/10.1080/15563650.2017.1296154.
- 9. and , “Acute Respiratory Distress Syndrome: Causes, Pathophysiology, and Phenotypes,” Lancet 400, no. 10358 (2022): 1145–1156, https://doi.org/10.1016/S0140-6736(22)01485-4.
- 10. , “Toxin-Induced Respiratory Distress,” Emergency Medicine Clinics of North America 32, no. 1 (2014): 127–147, https://doi.org/10.1016/j.emc.2013.09.003.
- 11. , , , , , and , “ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits,” ASAIO Journal 68, no. 2 (2022): 133–152, https://doi.org/10.1097/MAT.0000000000001630.
- 12. , , and , “Critical Care Issues for the Nephrologist: Mechanical Ventilation in the Management of Acute Respiratory Distress Syndrome,” Seminars in Dialysis 19, no. 6 (2006): 517–524, https://doi.org/10.1111/j.1525-139X.2006.00215.x.
- 13. , , , , , and , “Extracorporeal Membrane Oxygenation for Acute Toxic Inhalations: Case Reports and Literature Review,” Frontiers in Medicine 8 (2021): 745555, https://doi.org/10.3389/fmed.2021.745555.
- 14. , , , , , and , “Extracorporeal Membrane Oxygenation Use in Poisoning: A Narrative Review With Clinical Recommendations,” Clinical Toxicology 59, no. 10 (2021): 877–887, https://doi.org/10.1080/15563650.2021.1945082.
- 15. , , , et al., “Extracorporeal Membrane Oxygenation for Poisonings Reported to U.S. Poison Centers From 2000 to 2018: An Analysis of the National Poison Data System,” Critical Care Medicine 48, no. 8 (2020): 1111–1119, https://doi.org/10.1097/CCM.0000000000004401.
- 16. , , , et al., “2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia,” Critical Care Medicine 52, no. 5 (2024): e219–e233, https://doi.org/10.1097/CCM.0000000000006172.
- 17. , , , et al., “Pharmacological Principles Guiding Prolonged Glucocorticoid Treatment in ARDS,” Intensive Care Medicine 46, no. 12 (2020): 2284–2296, https://doi.org/10.1007/s00134-020-06289-8.
- 18. and , “Inhalation Injury: Epidemiology, Pathology, Treatment Strategies,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 21, no. 1 (2013): 31, https://doi.org/10.1186/1757-7241-21-31.
- 19. , , , and , “Treatment of Chloramine-Induced Chemical Pneumonitis With Extracorporeal Membrane Oxygenation (ECMO) Following Bleach and Disinfectant Inhalation,” Clinical Toxicology 61, no. 2 (2023): 136–137, https://doi.org/10.1080/15563650.2022.2163902.
- 20. , , and , “Successful Management of Severe Acute Respiratory Distress Syndrome Caused by Sodium Polystyrene Sulfonate Aspiration: A Case Report,” Medicine 98, no. 30 (2019): e16574, https://doi.org/10.1097/MD.0000000000016574.
- 21. , , , , and , “Utilizing Extracorporeal Membrane Oxygenation and Surfactant in the Management of Severe Acute Respiratory Distress Syndrome Due to Hydrocarbon Pneumonitis,” Perfusion 39, no. 3 (2024): 615–619, https://doi.org/10.1177/02676591221148605.
